Development and evaluation of a next-generation digital PCR diagnostic assay for ocular Chlamydia trachomatis infections

Journal of Clinical Microbiology

Volumn 51, Issue 7, 2013, Pages 2195-2203

  Roberts, Chrissy H ^a   Last, Anna ^a   Molina Gonzalez, Sandra ^a   Cassama, Eunice ^b   Butcher, Robert ^a   Nabicassa, Meno ^b   McCarthy, Elizabeth ^a   Burr, Sarah E ^a   Mabey, David C ^a   Bailey, Robin L ^a   Holland, Martin J ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b Programa Nacional de Saude de Visao   (Guinea-Bissau)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA;

ADOLESCENT; AGED; ARTICLE; BACTERIUM DETECTION; BIOLOGICAL MONITORING; CHILD; CHLAMYDIA TRACHOMATIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC KIT; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DROPLET DIGITAL POLYMERASE CHAIN REACTION; ENDEMIC DISEASE; EYE EXAMINATION; FEMALE; GUINEA-BISSAU; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TRACHOMA; VALIDATION PROCESS; ADULT; COMPARATIVE STUDY; EVALUATION STUDY; INFANT; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; PROCEDURES; VERY ELDERLY; YOUNG ADULT;

CHLAMYDIA TRACHOMATIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTERIOLOGICAL TECHNIQUES; CHILD; CHILD, PRESCHOOL; CHLAMYDIA TRACHOMATIS; FEMALE; GUINEA-BISSAU; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; ROC CURVE; SENSITIVITY AND SPECIFICITY; TRACHOMA; YOUNG ADULT;

EID: 84879450139     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00622-13     Document Type: Article

References (51)

1. WHO. 2012. Global WHO alliance for the elimination of blinding trachoma by 2020. Wkly. Epidemiol. Rec. 87:161-168.
2. Burton MJ, Holland MJ, Makalo P, Aryee EAN, Alexander NDE, Sillah A, Faal H, West SK, Foster A, Johnson GJ, Mabey DCW, Bailey RL. 2005. Re-emergence of Chlamydia trachomatis infection after mass antibiotic treatment of a trachoma-endemic Gambian community: a longitudinal study. Lancet 365:1321-1328.
3. Chidambaram JD, Alemayehu W, Melese M, Lakew T, Yi E, House J, Cevallos V, Zhou Z, Maxey K, Lee DC, Shapiro BL, Srinivasan M, Porco T, Whitcher JP, Gaynor BD, Lietman TM. 2006. Effect of a single mass antibiotic distribution on the prevalence of infectious trachoma. JAMA 295:1142-1146.
4. Schachter J, West SK, Mabey D, Dawson CR, Bobo L, Bailey R, Vitale S, Quinn TC, Sheta A, Sallam S, Mkocha H, Faal H. 1999. Azithromycin in control of trachoma. Lancet 354:630-635.
5. Solomon AW, Holland MJ, Alexander NDE, Massae PA, Aguirre A, Natividad-Sancho A, Molina S, Safari S, Shao JF, Courtright P, Peeling RW, West SK, Bailey RL, Foster A, Mabey DCW. 2004. Mass treatment with single-dose azithromycin for trachoma. N. Engl. J. Med. 351:1962-1971.
6. West ES, Munoz B, Mkocha H, Holland MJ, Aguirre A, Solomon AW, Bailey R, Foster A, Mabey D, West SK, Any W. 2005. Mass treatment and the effect on the load of Chlamydia trachomatis infection in a trachoma-hyperendemic community. Invest. Ophthalmol. Vis. Sci. 46:83-87.
7. West SK, Munoz B, Mkocha H, Holland MJ, Aguirre A, Solomon AW, Foster A, Bailey RL. 2005. Infection with Chlamydia trachomatis after mass treatment of a trachoma hyperendemic community in Tanzania: a longitudinal study. Lancet 366:1296-1300.
8. Solomon AW, Holland MJ, Burton MJ, West SK, Alexander NDE, Aguirre A, Massae PA, Mkocha H, Muñoz B, Johnson GJ, Peeling RW, Bailey RL, Foster A. 2003. Strategies for control of trachoma: observational study with quantitative PCR. Lancet 362:198-204.
9. McGowin CL, Whitlock GC, Pyles RB. 2009. High-throughput multistrain polymerase chain reaction quantification of Chlamydia trachomatis from clinical and preclinical urogenital specimens. Diagn. Microbiol. Infect. Dis. 64:117-123.
10. Pickett MA, Everson JS, Pead PJ, Clarke IN. 2005. The plasmids of Chlamydia trachomatis and Chlamydophila pneumoniae (N16): accurate determination of copy number and the paradoxical effect of plasmidcuring agents. Microbiology 151:893-903.
11. Stevens MP, Twin J, Fairley CK, Donovan B, Tan SE, Yu J, Garland SM, Tabrizi SN. 2010. Development and evaluation of an ompA quantitative real-time PCR assay for Chlamydia trachomatis serovar determination. J. Clin. Microbiol. 48:2060-2065.
12. Wei H, Zou S, Yang X, Yang D, Chen X. 2012. Development of multiplex real-time quantitative PCR for simultaneous detection of Chlamydia trachomatis and Ureaplasma parvum. Clin. Biochem. 45:663-667.
13. Hindson BJ, Ness KD, Masquelier DA, Belgrader P, Heredia NJ, Makarewicz AJ, Bright IJ, Lucero MY, Hiddessen AL, Legler TC, Kitano TK, Hodel MR, Petersen JF, Wyatt PW, Steenblock ER, Shah PH, Bousse LJ, Troup CB, Mellen JC, Wittmann DK, Erndt NG, Cauley TH, Koehler RT, So AP, Dube S, Rose KA, Montesclaros L, Wang S, Stumbo DP, Hodges SP, Romine S, Milanovich FP, White HE, Regan JF, Karlin-Neumann GA, Hindson CM, Saxonov S, Colston BW. 2011. High-throughput droplet digital PCR system for absolute quantitation of DNA copy number. Anal. Chem. 83:8604-8610.
14. Pinheiro LB, Coleman VA, Hindson CM, Herrmann J, Hindson BJ, Bhat S, Emslie KR. 2012. Evaluation of a droplet digital polymerase chain reaction format for DNA copy number quantification. Anal. Chem. 84: 1003-1011.
15. Vogelstein B, Kinzler KW. 1999. Digital PCR. Proc. Natl. Acad. Sci. U. S. A. 96:9236-9241.
16. Tan Y-C, Cristini V, Lee AP. 2006. Monodispersed microfluidic droplet generation by shear focusing microfluidic device. Sens. Actuators B Chem. 114:350-356.
17. Leng X, Zhang W, Wang C, Cui L, Yang CJ. 2010. Agarose droplet microfluidics for highly parallel and efficient single molecule emulsion PCR. Lab Chip 10:2841-2843.
18. Dube S, Qin J, Ramakrishnan R. 2008. Mathematical analysis of copy number variation in a DNA sample using digital PCR on a nanofluidic device. PLoS One 3:e2876. doi:10.1371/journal.pone.0002876.
19. Kalinina O, Lebedeva I, Brown J, Silver J. 1997. Nanoliter scale PCR with TaqMan detection. Nucleic Acids Res. 25:1999-2004.
20. Nakano M, Komatsu J, Matsuura S, Takashima K, Katsura S, Mizuno A. 2003. Single-molecule PCR using water-in-oil emulsion. J. Biotechnol. 102:117-124.
21. Vincent ME, Liu W, Haney EB, Ismagilov RF. 2010. Microfluidic stochastic confinement enhances analysis of rare cells by isolating cells and creating high density environments for control of diffusible signals. Chem. Soc. Rev. 39:974-984.
22. Hayden RT, Gu Z, Ingersoll J, Abdul-Ali D, Shi L, Pounds S, Caliendo AM. 2013. Comparison of droplet digital PCR to real-time PCR for quantitative detection of cytomegalovirus. J. Clin. Microbiol. 51:540-546.
23. Henrich TJ, Gallien S, Li JZ, Pereyra F, Kuritzkes DR. 2012. Low-level detection and quantitation of cellular HIV-1 DNA and 2-LTR circles using droplet digital PCR. J. Virol. Methods 186:68-72.
24. White RA, Quake SR, Curr K. 2012. Digital PCR provides absolute quantitation of viral load for an occult RNA virus. J. Virol. Methods 179: 45-50.
25. Luo W, Yang H, Rathbun K, Pau C-P, Ou C-Y. 2005. Detection of human immunodeficiency virus type 1 DNA in dried blood spots by a duplex real-time PCR assay. J. Clin. Microbiol. 43:1851-1857.
26. Wang Y, Kahane S, Cutcliffe LT, Skilton RJ, Lambden PR, Clarke IN. 2011. Development of a transformation system for Chlamydia trachomatis: restoration of glycogen biosynthesis by acquisition of a plasmid shuttle vector. PLoS Pathog. 7:e1002258. doi:10.1371/journal.ppat.1002258.
27. Bennett S, Woods T, Liyanage WM, Smith DL. 1991. A simplified general method for cluster-sample surveys of health in developing countries. World Health Stat. Q. 44:98-106.
28. Harding-Esch EM, Edwards T, Sillah A, Sarr-Sissoho I, Aryee EA, Snell P, Holland MJ, Mabey DC, Bailey RL. 2008. Risk factors for active trachoma in The Gambia. Trans. R. Soc. Trop. Med. Hyg. 102:1255-1262.
29. Solomon AW, Zondervan M, Kuper H, Buchan JC, Mabey DCW, Foster A. 2006. Trachoma control: a guide for programme managers. World Health Organization, Geneva, Switzerland.
30. Andreasen AA, Burton MJ, Holland MJ, Polley S, Faal N, David CW, Bailey RL. 2008. Chlamydia trachomatis ompA variants in trachoma: what do they tell us? PLoS Negl. Trop. Dis. 2:e306. doi:10.1371/journal.pntd.0000306
31. Burton MJ, Ramadhani A, Weiss HA, Hu V, Massae P, Burr SE, Shangali W, Holland MJ, Mabey DCW, Bailey RL. 2011. Active trachoma is associated with increased conjunctival expression of IL17A and profibrotic cytokines. Infect. Immun. 79:4977-4983.
32. Harding-Esch EM, Edwards T, Sillah A, Sarr I, Roberts CH, Snell P, Aryee E, Molina S, Holland MJ, Mabey DCW, Bailey RL. 2009. Active trachoma and ocular Chlamydia trachomatis infection in two Gambian regions: on course for elimination by 2020? PLoS Negl. Trop. Dis. 3:e573. doi:10.1371/journal.pntd. 0000573.
33. Harding-Esch EM, Holland MJ, Schémann Molina J-FS, Sarr I, Andreasen AA, Roberts CH, Sillah A, Sarr B, Harding EF, Edwards T, Bailey RL, Mabey DCW. 2011. Diagnostic accuracy of a prototype point-of-care test for ocular Chlamydia trachomatis under field conditions in The Gambia and Senegal. PLoS Negl. Trop. Dis. 5:e1234. doi:10.1371/journal.pntd.0001234.
34. Stare D, Harding-Esch E, Munoz B, Bailey R, Mabey D, Holland M, Gaydos C, West S. 2011. Design and baseline data of a randomized trial to evaluate coverage and frequency of mass treatment with azithromycin: the Partnership for Rapid Elimination of Trachoma (PRET) in Tanzania and The Gambia. Ophthalmic Epidemiol. 18:20-29.
35. Bass CA, Jungkind DL, Silverman NS, Bondi JM. 1993. Clinical evaluation of a new polymerase chain reaction assay for detection of Chlamydia trachomatis in endocervical specimens. J. Clin. Microbiol. 31:2648-2653.
36. Bassiri M, Mårdh PA, Domeika M. 1997. Multiplex AMPLICOR PCR screening for Chlamydia trachomatis and Neisseria gonorrhoeae in women attending non-sexually transmitted disease clinics. J. Clin. Microbiol. 35: 2556-2560.
37. Cheng A, Qian Q, Kirby JE. 2011. Evaluation of the Abbott RealTime CT/NG assay in comparison to the Roche Cobas Amplicor CT/NG assay. J. Clin. Microbiol. 49:1294-1300.
38. Jaschek G, Gaydos CA, Welsh LE, Quinn TC. 1993. Direct detection of Chlamydia trachomatis in urine specimens from symptomatic and asymptomatic men by using a rapid polymerase chain reaction assay. J. Clin. Microbiol. 31:1209-1212.
39. Miyashita N, Lijima Y, Matsumoto A. 1994. Evaluation of the sensitivity and specificity of polymerase chain reaction test kit, AMPLICOR Chlamydia trachomatis. Microbiol. Immunol. 38:81-85.
40. Rumpianesi F, La Placa M, D'Antuono A, Negosanti M, Pavan G. 1993. Assessment of the "Amplicor" PCR test in the diagnosis of Chlamydia trachomatis infection. New Microbiol. 16:293-295.
41. Van Der Pol B, Martin DH, Schachter J, Quinn TC, Gaydos CA, Jones RB, Crotchfelt K, Moncada J, Jungkind D, Turner B, Peyton C, Kelly JF, Weiss JB, Rosenstraus M. 2001. Enhancing the specificity of the COBAS AMPLICOR CT/NG test for Neisseria gonorrhoeae by retesting specimens with equivocal results. J. Clin. Microbiol. 39:3092-3098.
42. Vincelette J, Schirm J, Bogard M, Bourgault AM, Luijt DS, Bianchi A, Van Voorst Vader PC, Butcher A, Rosenstraus M. 1999. Multicenter evaluation of the fully automated COBAS AMPLICOR PCR test for detection of Chlamydia trachomatis in urogenital specimens. J. Clin. Microbiol. 37:74-80.
43. Banoo S, Bell D, Bossuyt P, Herring A, Mabey D, Poole F, Smith PG, Sriram N, Wongsrichanalai C, Linke R, O'Brien R, Perkins M, Cunningham J, Matsoso P, Nathanson CM, Olliaro P, Peeling RW, Ramsay A. 2006. Evaluation of diagnostic tests for infectious diseases: general principles. Nat. Rev. Microbiol. 4:S20-S32.
44. Vihinen M. 2012. How to evaluate performance of prediction methods? Measures and their interpretation in variation effect analysis. BMC Genomics 13(Suppl 4):S2.
45. Burton MJ, Holland MJ, Makalo P, Aryee EAN, Sillah A, Cohuet S, Natividad A, Alexander NDE, Mabey DCW, Bailey RL. 2010. Profound and sustained reduction in Chlamydia trachomatis in The Gambia: a fiveyear longitudinal study of trachoma endemic communities. PLoS Negl. Trop. Dis. 4:e835. doi:10.1371/journal. pntd.0000835.
46. Solomon AW, Harding-Esch E, Alexander NDE, Aguirre A, Holland MJ, Bailey RL, Foster A, Mabey DCW, Massae PA, Courtright P, Shao JF. 2008. Two doses of azithromycin to eliminate trachoma in a Tanzanian community. N. Engl. J. Med. 358:1870-1871.
47. Skalet AH, Cevallos V, Ayele B, Gebre T, Zhou Z, Jorgensen JH, Zerihun M, Habte D, Assefa Y, Emerson PM, Gaynor BD, Porco TC, Lietman TM, Keenan JD. 2010. Antibiotic selection pressure and macrolide resistance in nasopharyngeal Streptococcus pneumoniae: a clusterrandomized clinical trial. PLoS Med. 7:e1000377. doi:10.1371/journal.pmed.1000377.
48. Yang JL, Schachter J, Moncada J, Habte D, Zerihun M, House JI, Zhou Z, Hong KC, Maxey K, Gaynor BD, Lietman TM. 2007. Comparison of an rRNA-based and DNA-based nucleic acid amplification test for the detection of Chlamydia trachomatis in trachoma. Br. J. Ophthalmol. 91:293-295.
49. Green TA, Black CM, Johnson RE. 2001. In defense of discrepant analysis. J. Clin. Epidemiol. 54:210-211.
50. Hadgu A. 1999. Discrepant analysis: a biased and an unscientific method for estimating test sensitivity and specificity. J. Clin. Epidemiol. 52:1231-1237.
51. Keenan JD, See CW, Moncada J, Ayele B, Gebre T, Stoller NE, McCulloch CE, Porco TC, Gaynor BD, Emerson PM, Schachter J, Lietman TM. 2012. Diagnostic characteristics of tests for ocular Chlamydia after mass azithromycin distributions. Invest. Ophthalmol. Vis. Sci. 53:235-240.